Crossmark

Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies

Crossref DOI link: https://doi.org/10.1245/s10434-022-12698-4

Published Online: 2022-11-18

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ramos Arias, Gabriel

Sindayigaya, Rémy

Ouaissi, Mehdi

Buggisch, Jonathan R.

Schmeding, Maximilian

Giger-Pabst, Urs

Zieren, Jürgen
License Information

Text and Data Mining valid from 2022-11-18

Version of Record valid from 2022-11-18
More Information

Article History

Received: 21 July 2022

Accepted: 4 October 2022

First Online: 18 November 2022

DISCLOSURES

: Gabriel Ramos Arias, Rémy Sindayigaya, Mehdi Ouaissi, Jonathan R. Buggisch, Maximilian Schmeding, Urs Giger-Pabst, and Jürgen Zieren have no conflicts of interest or financial ties to disclose.

Document is current

Any future updates will be listed below